FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 11:56:04 28/06/2024 pm IST | ||
| 4.32 EUR | +1.41% |
|
| Current month | +12.50% | ||
| 1 month | +29.73% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 4.32 | +1.41% |
| 27/24/27 | 4.26 | -6.78% |
| 26/24/26 | 4.57 | -20.38% |
| 25/24/25 | 5.74 | +12.77% |
| 24/24/24 | 5.09 | +17.28% |
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 11:56 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GZ9F86 |
| ISIN | DE000GZ9F863 |
| Date issued | 01/03/2023 |
| Strike | 282.3 $ |
| Maturity | Unlimited |
| Parity | 6.54 : 1 |
| Emission price | 8.84 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 25.56 € |
|---|---|
| Lowest since issue | 1.72 € |
| Spread | 0.07 € |
| Spread % | 1.59% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Certificates
- Certificat
